An early report of a new study shows that the first-generation bisphosphonate, Didronel, in combination with the cholesterol drug Lipitor, reduced abdominal aortic plaques by about 12% in people with high cholesterol, compared to 1% in people on Lipitor alone.

Click here to read the full story.

No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.